Quick Answer
ImmunityBio, Inc. reported Common Stock Shares Outstanding of 1.01 billion shares for the year ending 2025.
- ImmunityBio, Inc. showed an increase of +18.6% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from ImmunityBio, Inc.'s annual report (Form 10-K), filed with the SEC on February 23, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), ImmunityBio, Inc.'s Common Stock Shares Outstanding has grown by 1,144.3%.
- Historical annual values: Fiscal year 2025: 1.01 billion shares | Fiscal year 2024: 852.90 million shares | Fiscal year 2023: 670.87 million shares | Fiscal year 2022: 421.57 million shares | Fiscal year 2021: 397.83 million shares | Fiscal year 2020: 382.24 million shares | Fiscal year 2019: 98.46 million shares | Fiscal year 2018: 79.09 million shares | Fiscal year 2017: 79.02 million shares | Fiscal year 2016: 81.98 million shares | Fiscal year 2015: 81.31 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: